Totus Medicines is a biopharmaceutical company developing precision oral medicines against historically "undruggable" disease targets. The company's OmniDEL discovery platform screens targets in their normal cellular environment to identify potent, selective covalent small molecules, drawing on precedents like penicillin and AZT.
company drug-discovery immunology biotechnology precision-medicine oncology apis-json biopharmaceutical covalent-small-molecules
-
Updated
Aug 4, 2026